Summary:
- The article discusses the role of the gut microbiome in the development and progression of autoimmune diseases, with a focus on rheumatoid arthritis (RA).
- It highlights how alterations in the gut microbiome, known as dysbiosis, can contribute to the development of RA by triggering an abnormal immune response and inflammation.
- The article explores potential therapeutic approaches targeting the gut microbiome, such as probiotics and fecal microbiota transplantation, as promising strategies for managing autoimmune conditions like RA.